Cromos Pharma, where the patients are

Global News

Tisch MS Research Center uses crowdfunding to finance clinical trial

Friday, April 4, 2014 11:07 AM

Culminating 10 years of stem cell research for the treatment of progressive multiple sclerosis (MS), the Tisch MS Research Center in New York has raised more than $244,000 through donation-based crowdfunding in less than three weeks for a 20-patient phase I clinical trial that researchers say has the potential to repair the damage caused by the chronic disease that attacks the central nervous system.

More... »

CRF Health eCOA webinar series

Medidata wins award for innovative mobile app that engages patients in clinical trials

Thursday, April 3, 2014 11:38 AM

Medidata, a global provider of cloud-based solutions for clinical research in life sciences, won the Patient Engagement App Challenge (large organization category) at the 23rd Annual Partnerships in Clinical Trials Conference with a unique mobile app. The award recognizes Engage, Medidata’s app prototype, for its potential to positively transform the clinical trial experience for study participants at a time when capturing the voice of the patient is becoming increasingly important.

More... »


Icon awarded best CRO at World Vaccines Congress 2014

Thursday, April 3, 2014 11:33 AM

Icon,a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has been named Best Clinical Research Organization in the Vaccine Industry Excellence (ViE) Awards.

More... »

Glythera makes appointments to support company expansion

Thursday, April 3, 2014 11:26 AM

Glythera, a biotechnology company specializing in the development of next generation bio-therapeutics, including Antibody Drug Conjugates,  through the application of its proprietary linker and stable glycan technologies PermaLink and PermaCarb, has appointed of Nigel Burns as non-executive director and Ian Evetts as commercial director. Glythera has recently validated data from their core technologies and the addition of Burns and Evetts coincides with the company’s expansion plan exploring new opportunities to provide essential support during the company’s growth plan.

More... »

Acceleration Laboratory earns four out of five CRO Leadership Awards

Thursday, April 3, 2014 11:20 AM

Acceleration Laboratory Services, a unit of CRO Acceleration Scientific, has announced their acceptance of the 2014 CRO Leadership Awards from Life Science Leader magazine in the categories of regulatory, innovation, productivity and reliability. The CRO Leadership Awards are based on responses of more than 10,000 pharmaceutical and biopharmaceutical executives to a survey conducted by Nice Insight and sponsored by Life Science Leadermagazine. The awards recognize those contract research and service organizations that are the most highly rated by industry respondents.

More... »

Clinical Conductor CTMS releases first collaborative CTMS

Thursday, April 3, 2014 11:09 AM

Clinical Conductor, the industry’s first collaborative and configurable CTMS for organizations managing or executing clinical trials, created by Bio-Optronics, a provider of software and services to healthcare and life sciences organizations around the world, has released a new Clinical Conductor CTMS revolutionizing clinical trial collaboration. The financial capabilities of Clinical Conductor also have been strengthened by the release and provide users enhanced levels of clarity and granularity of their trial finances, allowing them to maximize profitability and more easily ensure billing compliance.

More... »

Baxter to acquire Chatham Therapeutics

Thursday, April 3, 2014 11:08 AM

Baxter International, a global, diversified healthcare company, has agreed to acquire all of Chatham Therapeutics’ outstanding membership interests. Chatham is a privately held clinical development-stage biotechnology company. As a result, Baxter will acquire Chatham’s developmental gene therapy programs directed toward the development and commercialization of treatments for hemophilia.

More... »

EnVivo Pharmaceuticals becomes FORUM Pharmaceuticals

Thursday, April 3, 2014 10:57 AM

EnVivo Pharmaceuticals has changed its name to FORUM Pharmaceuticals. The new name better reflects the company’s strong position as a late-stage, purpose-built organization that is focused on conquering brain diseases such as schizophrenia and Alzheimer’s disease. It is not associated with any changes in organizational structure or the company’s investor base.

More... »

Evotec, Debiopharm Group to collaborate on new treatment for cancer

Thursday, April 3, 2014 10:55 AM

Evotec has formed a research collaboration and licensing deal with Debiopharm Group, a Swiss-based global biopharmaceutical group, to identify and develop novel compounds having the potential to treat multiple forms of solid tumors and leukemia’s with defined genetic alterations. Discovery and preclinical development efforts will be driven by Evotec, while Debiopharm will manage clinical development. Evotec will receive R&D funding and high double-digit total payments triggered by clinical, regulatory and commercial milestones, plus royalties on sales of resulting commercial products.

More... »

TI Pharma in $13M consortium addressing neglected parasitic diseases

Wednesday, April 2, 2014 02:00 PM

Five academic institutions, two governmental institutes and two leading SMEs from Europe, Africa and Latin America are joining forces to develop novel drugs against parasites. The four-year E.U.-funded project led by VU University Amsterdam is called PDE4NPD: PhosphoDiEsterase inhibitors for Neglected Parasitic Diseases.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs